DNMT3B and rhabdomyosarcoma: Likewise, another study indicated that overexpression of DNMT3B contributes to radiotherapy failure, such that its inhibition represents a promising radiosensitizing strategy for patients with metastatic or recurrent rhabdomyosarcoma tumors [57].